Results
Sai Parenterals Q4 FY26 Earnings Call Transcript
Sai Parenterals held its first earnings call as a listed company, discussing Q4 and FY26 results and providing FY27 guidance of INR750 crore revenue with 17% EBITDA margin.
The company completed the t
